| Literature DB >> 36092118 |
Simón Ramírez1, Gonzalo Miguez1, Vanetza E Quezada-Scholz1, Luis Pardo1, Felipe Alfaro2, Felipe I Varas1, Mario A Laborda1.
Abstract
Pre and perinatal administration of Tetrahydrocannabinol (THC) in rodents and their offspring has many effects that have been studied using different methods that have not been integrated using quantitative methods. The effect of THC administration on behavior can be better understood by meta-analytic techniques. We examined whether there is an overall effect on the behavior of the offspring when THC is administered to mothers. Eligibility criteria included experiments using an experimental design with a control group without THC, in which THC is administered to mothers during pregnancy and lactation in rodents, and in which at least one type of behavioral (locomotor, emotional or cognitive) measurement in the offspring was implemented. Cohen's d was obtained for each study, then each individual study was weighted, and moderator analysis was performed. Analysis was performed using fixed and random effect models, and the heterogeneity was assessed by calculating Qb, I 2 and the prediction interval. Furthermore, 3 sub-meta-analyses were carried out according to the type of behavior. The general analysis determined a low weighted effect size of THC on the behavior of the offspring, moderated by type of rat strain. The sub-meta-analyses showed a medium effect for cognitive effects of THC in the offspring, and a low effect on locomotor activity and emotional behavior. In addition, publication bias was not detected. More research is needed to contribute to the understanding of the effect of THC exposure on offspring.Entities:
Keywords: Tetrahydrocannabinol (THC); behavior; drugs; mothers; offspring; rodents
Year: 2022 PMID: 36092118 PMCID: PMC9462465 DOI: 10.3389/fpsyg.2022.934600
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Flowchart for the search of articles and its selection. The boxes in the left columns indicate the number of articles selected. Each arrow indicates the detection procedure. The boxes in the right column show the number of articles excluded due to each eligibility criteria.
Study characteristics.
| N | First author | Cannabinoid receptor agonist | Doses | Period | Lifetime dose | Route | Behavior | Sex and strain | Test age | Result |
| 1 |
| WIN | 0.5 mg/kg | GD5 to GD20 | 8 mg/kg | S.C. | Cognitive, Emotional | Male Wistar | PND 6, 8, 10, and 12 | Decreased performance in homing behavior (learning and memory), Decreased separation-induced ultrasonic vocalization |
| 2 |
| WIN | 0.5 mg/kg | GD5 to GD20 | 8 mg/kg | S.C. | Emotional, Mixed cognitive emotional | Male–Female Wistar | PND ≥ 90 | Decreased playing and social behavior, No change in discrimination task, No change in time spend in open arms EPM |
| 3 |
| THC | 10 mg/kg | GD10 to GD12 | 30 mg/kg | S.C. | Locomotor activity | Male Wistar | PND9, 13, 17, and 21 | Increased locomotor activity |
| 4 |
| WIN | 0.5 and 1 mg/kg | GD5 to GD20 | 8 mg/kg and 16 mg/kg | S.C. | Cognitive | Male Long-Evans | PND40, 60, and 80 | No effect on prepulse inhibition |
| 5 |
| THC | 5 mg/Kg | GD15 to PND 9 | 80 mg/kg | Oral | Cognitive | Male Wistar | PND81 | Decreased smell memory in a social discrimination task. |
| 6 |
| THC | 5 mg/Kg | GD15 to PND 9 | 80 mg/kg | Oral | Mixed emotional cognitive | Male Sprague-Dawley | PND180 | Decreased time in social interaction, Decreased discrimination index of a new object |
| 7 |
| THC | 0.1 0.5, and 2 mg/Kg | GD5 to PND 24 | 3.9, 19.5, and 78 mg/kg | S.C. | Locomotor activity | Male-female Wistar | PND70 | Decreased locomotor activity |
| 8 |
| WIN | 0.5 mg/Kg | GD 5 to GD20 | 8 mg/Kg | S.C. | Locomotor activity | Male Wistar | PND12, 40 and 80 | Increased locomotor activity |
| 9 |
| THC | 1, 5, and 20 mg/Kg | GD5 to PND 24 | 30, 150, and 600 mg/kg | Oral | Mixed Locom-Emot, Emotional | Male-female Wistar | PND15, 20, 30, 40, and 70 | Increased Locomotor activity, Decreased emotional reactivity (more time in open arms), Increases emotional activity, No change in spontaneous locomotor activity |
| 10 |
| THC | 5 mg/kg | GD5 to PND24 | 150 mg/kg | Oral | Emotional, Locomotor | Male-Female Wistar | PND20, 30, 40, and 70 | Increased emotional reactivity, rearing increase, Increased emotional reactivity, reactivity to novelty increase, No change in locomotor activity |
| 11 |
| THC | 4 mg/kg | GD1 to PND10 | 40 mg/kg | S.C. | Emotional | Male Long-Evans | PND93, 97, and 99 | Increased emotional reactivity (Decreased time spent in the center of the open arena), Increased emotional activity (increases sniffing behavior), No change in forced swimming test |
| 12 |
| THC | 5 mg/kg | GD 5 to PND24 | 225 mg/kg | Oral | Mixed Locom-Emot, Emotional | Male -female Wistar | PND70 | Increased emotional reactivity rearing, sniffing, grooming, Increased locomotor activity, Decreased emotional reactivity (Increased open arm entries and open arm time in the EPM) |
| 13 |
| WIN | 0.5 mg/kg | GD 5 to GD20 | 8.5 mg/kg | S.C. | Mixed Locom-Emot | Male Wistar | PND22, 36 and 50 | Decreased coordination time in a rotarod, Decreased sniffing and increased grooming, No effect in time spent in the center of the open field, Decreased Locomotor activity |
| 14 |
| THC | 0.15 mg/Kg | GD 1 to GD 21 | 3.15 mg/kg | I.V. | Cognitive | Male -Female Sprague-Dawley | PND22 and 23 | Decreased passive avoidance retention (Memory), Decreased active place avoidance (behavioral plasticity), Decreased Attention (more trails to complete a attentional task) |
| 15 |
| THC | 2.5 and 5 mg/Kg, | GD15 to PND9 | 40–80 mg/kg | Oral | Mixed Locom-Emot, Emotional | Male Wistar | PND12 | Increased separation-induced ultrasonic vocalization, Decreased emotional behavior (social interaction), Increased emotional behavior (playing) |
Specific characteristics and their categories of each study with their respective UA. It is divided into treatment of mothers, and the measurement and the subjects’ behavioral tasks. S.C, subcutaneous; I.V, Intravenous injection; PND, Postnatal day; GD, Gestational day; THC, Delta-9-tetrahydrocannabinol; WIN, WIN 55,212-2; EPM, elevated plus maze.
FIGURE 2Forest plot of the effect sizes and estimated confidence intervals of all Unit of Analysis (UA). For the integrated effect size Cohen’s d was used. The lines indicate the effect sizes of each UA and its corresponding 95% confidence intervals. The last two lines represent the result under a fixed and random effect model, respectively. The lower and upper limits, the p-values and the variance of each UA are reported.
Summary of moderator analysis.
| Category | Size effect | 95% IC | Null test | Heterogeneity test d | Critical Q | ||||
| k | d | Se | L.I. | L.U. | Z | Qb |
| Z | |
|
| |||||||||
| Wistar | 20 | –0.182 | 0.081 | –0.339 | –0.024 | –2.225 | 7.042 | 2 | 5.99 |
| Sprague-Dawley | 4 | –0.384 | 0.165 | –0.076 | –0.061 | –3.329 | |||
| Long Evans | 4 | 0.271 | 0.190 | –0.102 | 0.644 | 1.424 | |||
|
| |||||||||
| THC | 18 | –0.045 | 0.091 | –0.242 | 0.133 | –0.498 | 3.419 | 1 | 5.84 |
| WIN | 10 | –0.297 | 0.101 | –0.494 | –0.507 | –2.943 | |||
|
| |||||||||
| High | 13 | –0.118 | 0.109 | –0.332 | 0.095 | –0.618 | 0.029 | 1 | 5.84 |
| Low | 15 | –0.184 | 0.086 | –0.353 | –0.015 | –4.502 | |||
|
| |||||||||
| Subcutaneous | 11 | –0.174 | 0.106 | –0.383 | –0.035 | –1.636 | 0.746 | 2 | 5.99 |
| Oral | 14 | –0.105 | 0.101 | –0.303 | –0.094 | –1.033 | |||
| Intravenous | 3 | –0.274 | 0.173 | –0.613 | 0.066 | –1.580 | |||
|
| |||||||||
| Emotional | 11 | –0.334 | 0.119 | –0.577 | –0.112 | –2.289 | 6.324 | 3 | 7.81 |
| Locomotor | 3 | –0.066 | 0.206 | –0.470 | 0.029 | –0.322 | |||
| Cognitive | 5 | –0.271 | 0.152 | –0.569 | –0.061 | −1786 | |||
| Mixed | 9 | –0.038 | 0.111 | –0.180 | 0.238 | 0.341 | |||
Each moderator group has its respective effect size. Qb and the critical Q are reported according to critical values of the chi-square table. Qb greater than the critical values represents that the null hypothesis is rejected. L.I., Lower limit; K, number of groups in the subcategory; d, weighted effect size; se, standard error; CI, confidence interval; Qb, statistical test homogeneity; df, degrees of freedom.
FIGURE 3Forest plot of the effect sizes and estimated confidence intervals of the UAs that evaluated locomotor activity. For the integrated effect size Cohen’s d was used. The lines indicate the effect sizes of each UA and its corresponding 95% confidence intervals. The last two lines represent the result under a fixed and random effect model, respectively. The lower and upper limits and the variance of each UA are reported.
FIGURE 5Forest plot of the effect sizes and estimated confidence intervals of the UAs that evaluated cognitive behavior. For the integrated effect size Cohen’s d was used. The lines indicate the effect sizes of each UA and its corresponding 95% confidence intervals. The last two lines represent the result under a fixed and random effect model, respectively. The lower and upper limits and the variance of each UA are reported.
FIGURE 6Funnel plot of publication bias created using the Trim and Fill method (Duval and Tweedie, 2000) shows an estimate of the effect sizes of all UAs. Data obtained from the experiments are shown in white. No data points were imputed.
FIGURE 7Funnel plot of publication bias for the locomotor activity sub-metaanalysis, created using the Trim and Fill method (Duval and Tweedie, 2000). It shows an estimate of the effect sizes of all UAs. Data obtained from the experiments are shown in white. No data points were imputed.
FIGURE 9Funnel plot of publication bias for the cognitive behavior sub-metaanalysis, created using the Trim and Fill method (Duval and Tweedie, 2000). It shows an estimate of the effect sizes of all UAs. Data obtained from the experiments are shown in white. No data points were imputed.